Skip to main content

Bellevue Group AG

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1674546 Zurich, V8

Position in RARE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$49,861,000
+$49,801,660 QoQ
Shares Held
2,380,000
+92148.1% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bellevue Group AG holds $2,583,944,637 across 59 Biotechnology names. RARE ranks #19 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RARE

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $49,861,000 2,380,000
2025-12-31 $59,340 2,580
2024-12-31 $168,280 4,000
2024-09-30 $222,200 4,000
2024-06-30 $164,400 4,000
2022-06-30 $1,849,460 31,000
2022-03-31 $1,866,334 25,700
2021-12-31 $1,765,890 21,000
2021-09-30 $2,516,301 27,900
2021-06-30 $2,040,490 21,400
2021-03-31 $4,668,260 41,000
2020-12-31 $5,675,630 41,000
2020-09-30 $3,369,790 41,000
2020-06-30 $1,877,280 24,000
2020-03-31 $955,245 21,500